VIATRIS INC. Proceeds from Sale of Other Productive Assets
VIATRIS INC. (VTRS) reported Proceeds from Sale of Other Productive Assets of $48.00 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-08.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfOtherProductiveAssets · last filed 2023-11-08
- VIATRIS INC. proceeds from sale of other productive assets for the quarter ending 2021-09-30 was $13.10M.
- VIATRIS INC. proceeds from sale of other productive assets for the quarter ending 2020-09-30 was $0.00.
| Period end | Proceeds from Sale of Other Productive Assets 3 month | Proceeds from Sale of Other Productive Assets 6 month | Proceeds from Sale of Other Productive Assets 9 month |
|---|---|---|---|
| 2023-09-30 | $48.00M 10-Q · filed 2023-11-08 | ||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-08 | ||
| 2021-09-30 | $13.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $96.50M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $83.40M 10-Q · filed 2021-08-09 | ||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $0.00 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |